Amicus Therapeutics is Changing Lives for People Who Have Diseases and Disorders that are Uncommon

Amicus is the American biopharmaceutical company that is located in Cranbury, New Jersey. Amicus Therapeutics went public back in the year 2007 where they operated under the NASDAQ symbol of FOLD. This business was created by many venture capital firms which included the firm Radius Ventures(Yahoo Finance). It also worked alongside of New Enterprise Associates.

The therapeutic focus for the business is surrounding orphan and rare diseases. It works to create a plan on different therapy options for various diseases and in 2014, the business was said to have the largest portfolio for small molecules within the pharmacological chaperones within the industry of pharmaceuticals.

There are a number of diseases out there that leaves patients without hope that they can be cured or treated. A specific example is of Fabry Disease. This disease is a genetic disorder and to help people overcome the disease, the latest product of Amicus Therapeutics is Migalastat. By creating a number of enzyme replacement therapies, patients who suffer from this disease are able to see a difference in their lives.

The goal of Amicus Therapeutics is to help patients who are suffering from a disease to live longer and healthier lives by allowing therapies to work to alleviate the symptoms of various diseases. They are very passionate and the work they are doing and are always thinking of different things to do to help patients. As long as they continue to push the idea of each therapy and to take a number of risks that will push for different advances to be made, more patients are able to be helped when they suffer from a genetic disorder or disease.

The goal of the company is to think outside of the box and to keep asking the questions that are the hardest to answer. The business knows that in order to make a difference, they have to know and understand the mistakes that have been made. Once you understand a mistake and know how to avoid it, you start to learn how to avoid it and bypass it the next time. It encourages more hope and promise which is what patients need when they suffer from a disease or disorder.

Check out Amicus Therapeutics on Twitter and Facebook

The Magnises Black Card is Millennials Golden Ticket

When you get your new black card from Magnises it will have a credit line of $0, until you link it with your bank or another card, but that’s not the real value of the Magnises card. Ask anyone who is lucky enough to have one, the real value is the prestige, that comes with having one. The Magnises card, created by entrepreneur Billy McFarland, is all about the perks. The website boasts a 24/7 concierge service that can arrange concert tickets, get reservations at the trendiest restaurants, and send you to the front of the line at clubs. It also promises to arrange you a ride in a BMW 7L with driver, a decided step up from Uber. Hop over.


Based on, all this luxury doesn’t come cheap, annual dues are $250 with Selects priced at $300, and even that won’t guarantee you the black metal card. Members need to be referred by someone on the inside, then vetted by a process resembling joining a fraternity. All prospective members are invited to the Wooster Street penthouse, where they can socialize with established members, making friends or not. The vetting lasts a couple of days, after which, you are excepted into the group or rejected. The final result riding more on how cool the group perceives you are. Check this out.


Indeed, owning the Magnises black card is your ticket into the equivalent of the cool kids table. But to millennials it is the perception of wealth that matters. It’s easier to network when you give the illusion of success. If it isn’t the golden ticket to the big time, it is at least a small taste of it.


Continue Reading at